Clinical trial
An Clinical Trial on the Efficacy and Safety of Shen Hai Long Capsule in the Treatment of Male Asthenospermia
NCT05745610 is registered in ClinicalTrials.gov with Zhongnan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Clinical Trial on the Efficacy and Safety of Shen Hai Long Capsule in the Treatment of Male Asthenospermia
- Lead sponsor
- Zhongnan Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 15, 2023
- Completion date
- December 31, 2024
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
efficacy and safety of shen hai long capsule for mild to moderate asthenospermia in men